Autologous Bone Marrow Mononuclear cell therapy
Showing 9976 - 10000 of >10,000
Acute Lymphoblastic Leukemia Ph Positive Trial in Spain (Imatinib)
Recruiting
- Acute Lymphoblastic Leukemia Ph Positive
-
Oviedo, Asturias, Spain
- +80 more
Jan 17, 2022
Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)
Recruiting
- Recurrent Leukemia
- Refractory Leukemia
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma
Recruiting
- Resectable Soft Tissue Sarcoma
- +4 more
- Hypofractionated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Osteoarthritis Trial in Greenslopes (G7 HA Acetabular Component, G7 PPS Acetabular Component)
Completed
- Osteoarthritis
- G7 HA Acetabular Component
- G7 PPS Acetabular Component
-
Greenslopes, Queensland, AustraliaGreenslopes Private Hospital
Jan 12, 2022
Sarcoma, Bone Tumor Trial in France (Patient specific instrument, Conventional surgical treatment)
Completed
- Sarcoma, Bone Tumor
- Patient specific instrument
- Conventional surgical treatment
-
Lille, France
- +7 more
Jul 27, 2021
Dry Age Related Macular Degeneration Trial in United States (MA09-hRPE)
Completed
- Dry Age Related Macular Degeneration
- MA09-hRPE
-
Los Angeles, California
- +3 more
Jul 4, 2021
Cultural Tailoring and Pilot Testing ofInpatient Yoga Therapy
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Cancer
- Yoga Sessions
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 27, 2022
Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint
Recruiting
- Pneumonitis, Interstitial
- +2 more
- Immune checkpoint blockade
- +2 more
-
Leuven, Flemish Brabant, BelgiumUniversitaire Ziekenhuizen Leuven
Mar 18, 2021
Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)
Recruiting
- Lung Cancer
- +2 more
- Antitumor therapy guided by organoid drug sensitivity test
-
Wuxi, Jiangsu, ChinaAffiliated Hospital of Jiangnan University
Feb 2, 2023
Efficacy, and Optimal Dose Finding Study for Multiple Myeloma
Recruiting
- Multiple Myeloma
-
Bucheon, Korea, Republic of
- +23 more
Dec 8, 2020
NSCLC Trial in Porto (Durvalumab, standard of care RT/RCT)
Recruiting
- Non-small Cell Lung Cancer
- Durvalumab
- standard of care RT/RCT
-
Porto, PortugalInstituto Português de Oncologia do Porto FG, EPE (IPO-Porto)
Feb 23, 2022
Sickle Cell Disease, Cognitive Impairment, Adolescent Behavior Trial in Birmingham (CREADY (Cognitive-Remediation of Executive
Recruiting
- Sickle Cell Disease
- +5 more
- CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jul 20, 2022
Sickle Cell Disease, Vaso-occlusive Crisis Trial in Rouen (Erythrocytic parameters and thrombin generation assay measurement)
Recruiting
- Sickle Cell Disease
- Vaso-occlusive Crisis
- Erythrocytic parameters and thrombin generation assay measurement
-
Rouen, FranceRouen university Hospital
May 17, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- (no location specified)
Aug 18, 2022
Fistula Vagina, Crohn Disease Trial in Rochester (MSC-AFP)
Completed
- Fistula Vagina
- Crohn Disease
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 28, 2020
Stage IIIA NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in Los Angeles (Laboratory Biomarker Analysis, Pembrolizumab)
Completed
- Stage IIIA Non-Small Cell Lung Cancer
- +2 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jun 24, 2021
Survival of Adult T-cell Leukemia / Lymphoma and Patients
Recruiting
- Lymphoproliferation Induced by HTLV-1
- +2 more
-
Paris, FranceHôpital Necker Enfants Malades
Sep 26, 2022
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
Active, not recruiting
- Non-small Cell Lung Cancer
- +3 more
- CT-scans extended
- +3 more
-
Odense, DenmarkDepartment of Oncology, Odense University Hospital
May 17, 2022
Mucositis Oral Trial in France (LLLT applied every other day, LLLT applied daily)
Unknown status
- Mucositis Oral
- LLLT applied every other day
- LLLT applied daily
-
Toulouse, Occitanie, France
- +15 more
Oct 15, 2020
Non Small Cell Lung Cancer Trial in Tianjin (Osimertinib, Bevacizumab Biosimilar IBI305, Carboplatin)
Recruiting
- Non Small Cell Lung Cancer
- Osimertinib
- +3 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 18, 2022
Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?
Not yet recruiting
- Locally Advanced Rectal Cancer
- +2 more
- nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Aug 11, 2023
Helicobacter Pylori Infection Trial (7days bismuth quadruple, 14 days bismuth quadruple)
Not yet recruiting
- Helicobacter Pylori Infection
- 7days bismuth quadruple
- 14 days bismuth quadruple
- (no location specified)
Aug 11, 2023
Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- Method(s)1 Attribution
- Method(s)2 Attribution,
-
Colorado Springs, ColoradoPNAF Medical
Nov 23, 2023
Schizophrenia, Psychosis, Psychotic Disorders Trial (Cognitive Behavioural Therapy for Psychosis (CBTp), Cognitive Remediation
Not yet recruiting
- Schizophrenia
- +3 more
- Cognitive Behavioural Therapy for Psychosis (CBTp)
- +3 more
- (no location specified)
Feb 7, 2023